Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines

Abstract excerpt

Use of clinical-grade human induced pluripotent stem cell (iPSC) lines as a starting material for the generation of cellular therapeutics requires demonstration of comparability of lines derived from different individuals and in different facilities. This requires agreement on the critical quality attributes of such lines and the assays that should be used. Working from established recommendations and guidance...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomedical Ethics and Regulation
• Share to CRISPR and Genetic Engineering
• Share to Pluripotent Stem Cells Research